三星医疗(601567) - 2016 Q3 - 季度财报
SANXINGSANXING(SH:601567)2016-10-24 16:00

Financial Performance - Operating revenue for the first nine months reached CNY 3,156,094,214.47, a 17.53% increase year-on-year[6] - Net profit attributable to shareholders was CNY 325,879,005.45, representing a 23.04% increase compared to the same period last year[7] - Total operating revenue for Q3 2016 was ¥1,246,667,127.96, an increase of 16.43% compared to ¥1,070,397,352.32 in Q3 2015[31] - Net profit for Q3 2016 reached ¥158,996,939.85, representing a 17.5% increase from ¥135,793,539.07 in Q3 2015[33] - The company reported a total profit of ¥201,830,530.72 for Q3 2016, an increase of 19.9% from ¥168,385,814.53 in Q3 2015[33] - Year-to-date revenue for 2016 reached CNY 1.24 billion, down 4.3% from CNY 1.30 billion in the same period last year[37] - Net profit for Q3 2016 was CNY 54.53 million, a decrease of 13.5% compared to CNY 63.36 million in Q3 2015[38] Assets and Liabilities - Total assets increased by 48.72% to CNY 11,037,798,994.58 compared to the end of the previous year[6] - Total liabilities increased to CNY 4,621,121,530.85 from CNY 4,334,377,322.64, which is an increase of about 6.6%[25] - Total assets as of Q3 2016 amounted to ¥8,196,692,900.15, compared to ¥5,137,711,551.34 in the same period last year, reflecting a growth of 59.96%[29] - Owner's equity increased to ¥6,174,122,146.07 in Q3 2016, up from ¥3,099,478,954.05 in Q3 2015, marking a growth of 99.67%[29] Shareholder Information - The total number of shareholders reached 28,652 by the end of the reporting period[12] - The largest shareholder, Aux Group Co., Ltd., holds 32.26% of the shares[12] - The number of shareholders holding unrestricted shares includes major stakeholders such as Aux Group Limited with 457,719,653 shares[15] Cash Flow - The net cash flow from operating activities was negative at CNY -81,512,014.08 for the first nine months[6] - Operating cash inflow for the first nine months reached ¥3,523,714,719.68, up from ¥2,800,008,913.91 in the previous year, representing a growth of approximately 25.8%[41] - Net cash flow from investment activities was negative at ¥803,549,560.89, improving from a negative ¥1,427,298,152.47 in the previous year[42] - Financing cash inflow amounted to ¥5,264,785,869.85, significantly higher than ¥3,947,071,304.41 in the same period last year, marking an increase of approximately 33.4%[42] Inventory and Receivables - Accounts receivable increased by 204.10% to RMB 103,611,565.22, mainly due to an increase in bill collections[16] - Inventory rose by 99.14% to RMB 878,106,333.55, attributed to increased sales scale and expanded production capacity[17] - The company reported a significant increase in prepayments, which rose to CNY 91,685,837.92 from CNY 43,817,770.29, reflecting a growth of approximately 109.1%[23] Other Financial Metrics - Basic and diluted earnings per share decreased by 3.45% to CNY 0.28[7] - The company reported a significant decrease in investment income, down 83.60% to RMB 10,406,037.69, due to losses from equity investments[17] - The company incurred asset impairment losses of CNY 4.69 million in Q3 2016, compared to CNY 1.43 million in Q3 2015[37] - The company experienced a decrease in other comprehensive income, reporting a loss of ¥1,273,463.21 in Q3 2016 compared to a gain of ¥410,171.62 in Q3 2015[34]